(Q34345239)

1 August 2017

1 reference

title

Comparative effects of pharmacotherapy on the maintenance of cognitive function (English)

1 reference

1 August 2017

0 references

Allain H

1

1 reference

1 August 2017

Schück S

series ordinal

2

1 reference

1 August 2017

Mauduit N

series ordinal

3

1 reference

1 August 2017

Djemai M

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

16 Suppl 1

1 reference

1 August 2017

page(s)

35s-41s

1 reference

The overlap between Alzheimer's disease and vascular dementia: the role of white matter changes

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Memory for places learned long ago is intact after hippocampal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Genetic enhancement of learning and memory in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Simple reaction time as a measure of global attention in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Effects of tiapride on electroencephalograms and cognitive functions in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

The role of Ca2+/calmodulin-stimulable adenylyl cyclases as molecular coincidence detectors in memory formation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Treatment of agitation in patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Acetylcholine and delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Long-term potentiation--a decade of progress?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Pick's disease, frontotemporal dementia, and Pick complex: emerging concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Hallucinations and associated factors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Melatonin, its receptors, and relationships with biological rhythm disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: evaluation of an observer-independent analytic approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Drugs that induce delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

General safety profile of zolpidem: safety in elderly, overdose and rebound effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

The impact of the symptoms of dementia on caregivers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Vascular risks and incident dementia: results from a cohort study of the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

A prospective study of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Neurochemistry and neurotransmitters.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Care of the delirious patient

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Quetiapine : A Review of its Use in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Behavioral disturbances of dementia in DSM-IV and ICD-10: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Familial dementia caused by polymerization of mutant neuroserpin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Experimental and clinical methods in the development of anti-Alzheimer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Delusions in Alzheimer's disease: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

The prevalence and phenomenology of psychotic symptoms in dementia sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Why there is a need for pharmacovigilance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900528-9

7 January 2021

10.1016/S0924-9338(00)00528-9

Identifiers

DOI

1 reference

1 August 2017

1 reference